{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:57:37Z","timestamp":1790873857908,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB779\/A06"],"award-info":[{"award-number":["SFB779\/A06"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Center of Clinical Research of the Medical Faculty Jena"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ketamine shows rapid antidepressant effects peaking 24\u2009h after administration. The antidepressant effects may occur through changes in glutamatergic metabolite levels and resting-state functional connectivity (rsFC) within the default mode network (DMN). A multistage drug effect of ketamine has been suggested, inducing acute effects on dysfunctional network configuration and delayed effects on homeostatic synaptic plasticity. Whether the DMN-centered delayed antidepressant-related changes are associated with the immediate changes remains unknown. Thirty-five healthy male participants (25.1\u2009\u00b1\u20094.2 years) underwent 7\u2009T magnetic resonance spectroscopy (MRS) and resting-state functional magnetic resonance imaging (rsfMRI) before, during, and 24\u2009h after a single S-ketamine or placebo infusion. Changes in glutamatergic measures and rsFC in the DMN node pregenual anterior cingulate cortex (pgACC) were examined. A delayed rsFC decrease of the pgACC to inferior parietal lobe (family-wise error corrected <jats:italic>p<\/jats:italic> (<jats:italic>p<\/jats:italic><jats:sub>FWEc<\/jats:sub>)\u2009=\u20090.018) and dorsolateral prefrontal cortex (PFC; <jats:italic>p<\/jats:italic><jats:sub>FWEc<\/jats:sub>\u2009=\u20090.002) was detected that was preceded by an immediate rsFC increase of the pgACC to medial PFC (<jats:italic>p<\/jats:italic><jats:sub>FWEc<\/jats:sub>\u2009&lt;\u20090.001) and dorsomedial PFC (<jats:italic>p<\/jats:italic><jats:sub>FWEc<\/jats:sub>\u2009=\u20090.005). Additionally, the immediate rsFC reconfigurations correlated with the delayed pgACC glutamate (Glu) level increase (<jats:italic>p<\/jats:italic>\u2009=\u20090.024) after 24\u2009h at trend level (<jats:italic>p<\/jats:italic>\u2009=\u20090.067). Baseline measures of rsFC and MRS were furthermore associated with the magnitude of the respective delayed changes (<jats:italic>p<\/jats:italic>\u2019s\u2009&lt;\u20090.05). In contrast, the delayed changes were not associated with acute psychotomimetic side effects or plasma concentrations of ketamine and its metabolites. This multimodal study suggests an association between immediate S-ketamine-induced network effects and delayed brain changes at a time point relevant in its clinical context.<\/jats:p>","DOI":"10.1038\/s41398-023-02346-0","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T14:03:52Z","timestamp":1676556232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine"],"prefix":"10.1038","volume":"13","author":[{"given":"Lena Vera","family":"Danyeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z\u00fcmr\u00fct Duygu","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Colic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kurzweil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9603","authenticated-orcid":false,"given":"Sabrina","family":"Gensberger-Reigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Macharadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-9931","authenticated-orcid":false,"given":"Florian","family":"G\u00f6tting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-1575","authenticated-orcid":false,"given":"Alexander","family":"Refisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Liebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-2737","authenticated-orcid":false,"given":"Moritz","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2296-0259","authenticated-orcid":false,"given":"Gerd","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-3298","authenticated-orcid":false,"given":"Nils","family":"Opel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jollant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias H. J.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-4483","authenticated-orcid":false,"given":"Martin","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","volume":"72","author":"BR Cornwell","year":"2012","unstructured":"Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, et al. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biol Psychiatry. 2012;72:555\u201361.","journal-title":"Biol Psychiatry"},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci J Soc Neurosci. 1997;17:2921\u20137.","journal-title":"J Neurosci J Soc Neurosci"},{"key":"2346_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000493425","volume":"5","author":"K Weckmann","year":"2019","unstructured":"Weckmann K, Deery MJ, Howard JA, Feret R, Asara JM, Dethloff F, et al. Ketamine\u2019s effects on the glutamatergic and GABAergic systems: a proteomics and metabolomics study in mice. Complex Psychiatry 2019;5:42\u201351.","journal-title":"Complex Psychiatry"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","volume":"224","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res. 2011;224:107\u201311.","journal-title":"Behav Brain Res"},{"key":"2346_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010;329:959\u201364.","journal-title":"Science"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"2346_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CAJ Zarate","year":"2006","unstructured":"Zarate CAJ, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"2346_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","volume":"72","author":"J Kryst","year":"2020","unstructured":"Kryst J, Kawalec P, Mitoraj AM, Pilc A, Laso\u0144 W, Brzostek T. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials. Pharm Rep. 2020;72:543\u201362.","journal-title":"Pharm Rep"},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"key":"2346_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00406-014-0535-3","volume":"264","author":"M Walter","year":"2014","unstructured":"Walter M, Li S, Demenescu LR. Multistage drug effects of ketamine in the treatment of major depression. Eur Arch Psychiatry Clin Neurosci. 2014;264:55\u201365.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"e1318","DOI":"10.4088\/JCP.17lr11789","volume":"78","author":"F Bartoli","year":"2017","unstructured":"Bartoli F, Clerici M, Carr\u00e0 G. Antidepressant response and dissociative effects after ketamine treatment: two sides of the same coin? J Clin Psychiatry. 2017;78:e1318.","journal-title":"J Clin Psychiatry"},{"key":"2346_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","volume":"159","author":"DA Luckenbaugh","year":"2014","unstructured":"Luckenbaugh DA, Niciu MJ, Ionescu DF, Nolan NM, Richards EM, Brutsche NE, et al. Do the dissociative side effects of ketamine mediate its antidepressant effects? J Affect Disord 2014;159:56\u201361.","journal-title":"J Affect Disord"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jad.2018.02.049","volume":"232","author":"MJ Niciu","year":"2018","unstructured":"Niciu MJ, Shovestul BJ, Jaso BA, Farmer C, Luckenbaugh DA, Brutsche NE, et al. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. J Affect Disord. 2018;232:310\u20135.","journal-title":"J Affect Disord"},{"key":"2346_CR14","first-page":"287","volume":"34","author":"P Sos","year":"2013","unstructured":"Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenicek T. Relationship of ketamine\u2019s antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinol Lett. 2013;34:287\u201393.","journal-title":"Neuro Endocrinol Lett"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.4088\/JCP.15m10056","volume":"77","author":"DF Ionescu","year":"2016","unstructured":"Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, et al. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry. 2016;77:e719\u201325.","journal-title":"J Clin Psychiatry"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","volume":"191","author":"GW Valentine","year":"2011","unstructured":"Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, et al. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res. 2011;191:122\u20137.","journal-title":"Psychiatry Res"},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry. 2015;72:603\u201311.","journal-title":"JAMA Psychiatry"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.1073\/pnas.1000446107","volume":"107","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci USA. 2010;107:11020\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","volume":"47","author":"DA Pizzagalli","year":"2022","unstructured":"Pizzagalli DA, Roberts AC. Prefrontal cortex and depression. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2022;47:225\u201346.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR20","first-page":"1049","volume":"4","author":"L Colic","year":"2019","unstructured":"Colic L, von D\u00fcring F, Denzel D, Demenescu LR, Lord AR, Martens L, et al. Rostral anterior cingulate glutamine\/glutamate disbalance in major depressive disorder depends on symptom severity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:1049\u201358.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2346_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","volume":"24","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24:952\u201364.","journal-title":"Mol Psychiatry"},{"key":"2346_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jad.2014.05.019","volume":"167","author":"MJ Taylor","year":"2014","unstructured":"Taylor MJ. Could glutamate spectroscopy differentiate bipolar depression from unipolar? J Affect Disord. 2014;167:80\u20134.","journal-title":"J Affect Disord"},{"key":"2346_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","volume":"68","author":"C Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel C, \u00d6ng\u00fcr D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 2010;68:785\u201394.","journal-title":"Biol Psychiatry"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/npp.2010.166","volume":"36","author":"DA Pizzagalli","year":"2011","unstructured":"Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2011;36:183\u2013206.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","volume":"65","author":"G Salvadore","year":"2009","unstructured":"Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CA Jr, et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry. 2009;65:289\u201395.","journal-title":"Biol Psychiatry"},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/npp.2010.24","volume":"35","author":"G Salvadore","year":"2010","unstructured":"Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2010;35:1415\u201322.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR27","doi-asserted-by":"publisher","first-page":"112907","DOI":"10.1016\/j.psychres.2020.112907","volume":"287","author":"J Zhang","year":"2020","unstructured":"Zhang J, Tian H, Li J, Ji S, Chen S, Zhu J, et al. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression. Psychiatry Res. 2020;287:112907.","journal-title":"Psychiatry Res"},{"key":"2346_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00406-018-0942-y","volume":"270","author":"M Li","year":"2020","unstructured":"Li M, Woelfer M, Colic L, Safron A, Chang C, Heinze HJ, et al. Default mode network connectivity change corresponds to ketamine\u2019s delayed glutamatergic effects. Eur Arch Psychiatry Clin Neurosci. 2020;270:207\u201316.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2346_CR29","doi-asserted-by":"publisher","first-page":"e44799","DOI":"10.1371\/journal.pone.0044799","volume":"7","author":"M Scheidegger","year":"2012","unstructured":"Scheidegger M, Walter M, Lehmann M, Metzger C, Grimm S, Boeker H, et al. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS ONE. 2012;7:e44799.","journal-title":"PLoS ONE"},{"key":"2346_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.euroneuro.2019.02.008","volume":"29","author":"M G\u00e4rtner","year":"2019","unstructured":"G\u00e4rtner M, Aust S, Bajbouj M, Fan Y, Wingenfeld K, Otte C, et al. Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2019;29:501\u20138.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"2346_CR31","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/scan\/nsw034","volume":"11","author":"M Lehmann","year":"2016","unstructured":"Lehmann M, Seifritz E, Henning A, Walter M, B\u00f6ker H, Scheidegger M, et al. Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network. Soc Cogn Affect Neurosci. 2016;11:1227\u201335.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","volume":"43","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, et al. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2018;43:2154\u201360.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/npp.2016.184","volume":"42","author":"M Li","year":"2017","unstructured":"Li M, Demenescu LR, Colic L, Metzger CD, Heinze HJ, Steiner J, et al. Temporal dynamics of antidepressant ketamine effects on glutamine cycling follow regional fingerprints of AMPA and NMDA receptor densities. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2017;42:1201\u20139.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol."},{"key":"2346_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","volume":"162","author":"LM Rowland","year":"2005","unstructured":"Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry. 2005;162:394\u20136.","journal-title":"Am J Psychiatry"},{"key":"2346_CR35","doi-asserted-by":"crossref","unstructured":"Weigand A, G\u00e4rtner M, Scheidegger M, Wyss PO, Henning A, Seifritz E, et al. Predicting antidepressant effects of ketamine: the role of the pregenual anterior cingulate cortex as a multimodal neuroimaging biomarker. Int J Neuropsychopharmacol. 2022;25:1003\u201313.","DOI":"10.1093\/ijnp\/pyac049"},{"key":"2346_CR36","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/npp.2016.186","volume":"42","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, et al. Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2017;42:1210\u20139.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.biopsych.2014.07.022","volume":"77","author":"A Anticevic","year":"2015","unstructured":"Anticevic A, Corlett PR, Cole MW, Savic A, Gancsos M, Tang Y, et al. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biol Psychiatry. 2015;77:569\u201380.","journal-title":"Biol Psychiatry"},{"key":"2346_CR38","doi-asserted-by":"publisher","unstructured":"G\u00e4rtner M, Weigand A, Scheidegger M, Lehmann M, Wyss PO, Wunder A, et al. Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism. Eur Arch Psychiatry Clin Neurosci. 2022; Available from: https:\/\/doi.org\/10.1007\/s00406-021-01377-2","DOI":"10.1007\/s00406-021-01377-2"},{"key":"2346_CR39","unstructured":"Diagnostic and statistical manual of mental disorders, 4th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 1994. xxvii, 886 p. (Diagnostic and statistical manual of mental disorders, 4th ed.)."},{"key":"2346_CR40","unstructured":"First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In: Comprehensive handbook of psychological assessment, Vol 2: Personality assessment. Hoboken, NJ, US: John Wiley & Sons, Inc.; 2004. p. 134\u201343."},{"key":"2346_CR41","unstructured":"Janssen Pharmaceuticals. Spravato, Full prescribing information. 2020;(Accessed 2 August 2020). Available from: http:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/SPRAVATO-pi.pdf. 2020."},{"key":"2346_CR42","doi-asserted-by":"crossref","unstructured":"Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol. 2008;313\u201333.","DOI":"10.1007\/978-3-540-74806-9_15"},{"key":"2346_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"G Sanacora","year":"2017","unstructured":"Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017;74:399\u2013405.","journal-title":"JAMA Psychiatry"},{"key":"2346_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","volume":"72","author":"CAJ Zarate","year":"2012","unstructured":"Zarate CAJ, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, et al. Relationship of ketamine\u2019s plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry. 2012;72:331\u20138.","journal-title":"Biol Psychiatry"},{"key":"2346_CR45","doi-asserted-by":"crossref","unstructured":"Dittrich A. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Vol. 31, Pharmacopsychiatry. Germany: Georg Thieme Verlag KG; 1998. p. 80\u20134.","DOI":"10.1055\/s-2007-979351"},{"key":"2346_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","volume":"11","author":"JD Bremner","year":"1998","unstructured":"Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, et al. Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS). J Trauma Stress. 1998;11:125\u201336.","journal-title":"J Trauma Stress"},{"key":"2346_CR47","doi-asserted-by":"publisher","first-page":"12698","DOI":"10.1523\/JNEUROSCI.1758-13.2013","volume":"33","author":"W Dou","year":"2013","unstructured":"Dou W, Palomero-Gallagher N, van Tol MJ, Kaufmann J, Zhong K, Bernstein HG, et al. Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex. J Neurosci. 2013;33:12698\u2013704.","journal-title":"J Neurosci."},{"key":"2346_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41592-018-0235-4","volume":"16","author":"O Esteban","year":"2019","unstructured":"Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2019;16:111\u20136.","journal-title":"Nat Methods"},{"key":"2346_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fninf.2011.00013","volume":"5","author":"K Gorgolewski","year":"2011","unstructured":"Gorgolewski K, Burns C, Madison C, Clark D, Halchenko Y, Waskom M, et al. Nipype: a flexible, lightweight and extensible neuroimaging data processing framework in python. Front Neuroinf. 2011;5:13.","journal-title":"Front Neuroinf."},{"key":"2346_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuroimage.2013.11.046","volume":"90","author":"G Salimi-Khorshidi","year":"2014","unstructured":"Salimi-Khorshidi G, Douaud G, Beckmann CF, Glasser MF, Griffanti L, Smith SM. Automatic denoising of functional MRI data: combining independent component analysis and hierarchical fusion of classifiers. NeuroImage 2014;90:449\u201368.","journal-title":"NeuroImage"},{"key":"2346_CR51","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroimage.2014.03.034","volume":"95","author":"L Griffanti","year":"2014","unstructured":"Griffanti L, Salimi-Khorshidi G, Beckmann CF, Auerbach EJ, Douaud G, Sexton CE, et al. ICA-based artefact removal and accelerated fMRI acquisition for improved resting state network imaging. NeuroImage 2014;95:232\u201347.","journal-title":"NeuroImage"},{"key":"2346_CR52","doi-asserted-by":"publisher","first-page":"122214","DOI":"10.1016\/j.jchromb.2020.122214","volume":"1152","author":"L Kurzweil","year":"2020","unstructured":"Kurzweil L, Danyeli L, \u015een ZD, Fejtova A, Walter M, Gensberger-Reigl S. Targeted mass spectrometry of ketamine and its metabolites cis-6-hydroxynorketamine and norketamine in human blood serum. J Chromatogr B Anal Technol Biomed Life Sci. 2020;1152:122214.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"2346_CR53","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0021-9681(62)90116-9","volume":"15","author":"PD Oldham","year":"1962","unstructured":"Oldham PD. A note on the analysis of repeated measurements of the same subjects. J Chronic Dis. 1962;15:969\u201377.","journal-title":"J Chronic Dis"},{"key":"2346_CR54","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.biopsych.2015.02.028","volume":"79","author":"Q Lv","year":"2016","unstructured":"Lv Q, Yang L, Li G, Wang Z, Shen Z, Yu W, et al. Large-Scale Persistent Network reconfiguration induced by ketamine in anesthetized monkeys: relevance to mood disorders. Biol Psychiatry. 2016;79:765\u201375.","journal-title":"Biol Psychiatry"},{"key":"2346_CR55","doi-asserted-by":"publisher","unstructured":"Martens MAG, Filippini N, Harmer CJ, Godlewska BR. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Psychopharmacology (Berl). 2021; Available from: https:\/\/doi.org\/10.1007\/s00213-021-05915-7","DOI":"10.1007\/s00213-021-05915-7"},{"key":"2346_CR56","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1073\/pnas.0812686106","volume":"106","author":"YI Sheline","year":"2009","unstructured":"Sheline YI, Barch DM, Price JL, Rundle MM, Vaishnavi SN, Snyder AZ, et al. The default mode network and self-referential processes in depression. Proc Natl Acad Sci USA. 2009;106:1942\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2346_CR57","doi-asserted-by":"crossref","unstructured":"Perrin JS, Merz S, Bennett DM, Currie J, Steele DJ, Reid IC. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci USA. 2012;109:5464\u20138.","DOI":"10.1073\/pnas.1117206109"},{"key":"2346_CR58","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1073\/pnas.0504136102","volume":"102","author":"MD Fox","year":"2005","unstructured":"Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA. 2005;102:9673\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2346_CR59","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1523\/JNEUROSCI.5587-06.2007","volume":"27","author":"WW Seeley","year":"2007","unstructured":"Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349\u201356.","journal-title":"J Neurosci"},{"key":"2346_CR60","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029\u201340.","journal-title":"Psychol Med"},{"key":"2346_CR61","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","volume":"6","author":"M Semkovska","year":"2019","unstructured":"Semkovska M, Quinlivan L, O\u2019Grady T, Johnson R, Collins A, O\u2019Connor J, et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6:851\u201361.","journal-title":"Lancet Psychiatry"},{"key":"2346_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jpsychires.2021.02.028","volume":"136","author":"A Stippl","year":"2021","unstructured":"Stippl A, Scheidegger M, Aust S, Herrera A, Bajbouj M, G\u00e4rtner M, et al. Ketamine specifically reduces cognitive symptoms in depressed patients: an investigation of associated neural activation patterns. J Psychiatr Res. 2021;136:402\u20138.","journal-title":"J Psychiatr Res"},{"key":"2346_CR63","first-page":"78","volume":"48","author":"A Permoda-Osip","year":"2015","unstructured":"Permoda-Osip A, Kisielewski J, Bartkowska-Sniatkowska A, Rybakowski JK. Single ketamine infusion and neurocognitive performance in bipolar depression. Pharmacopsychiatry 2015;48:78\u20139.","journal-title":"Pharmacopsychiatry"},{"key":"2346_CR64","doi-asserted-by":"publisher","first-page":"026988111982781","DOI":"10.1177\/0269881119827811","volume":"33","author":"W Zheng","year":"2019","unstructured":"Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, et al. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder. J Psychopharmacol (Oxf). 2019;33:026988111982781.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"2346_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jad.2022.03.041","volume":"307","author":"D DeMaster","year":"2022","unstructured":"DeMaster D, Godlewska BR, Liang M, Vannucci M, Bockmann T, Cao B, et al. Effective connectivity between resting-state networks in depression. J Affect Disord. 2022;307:79\u201386.","journal-title":"J Affect Disord"},{"key":"2346_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349.","journal-title":"Nat Med"},{"key":"2346_CR67","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","volume":"43","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, et al. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2018;43:2154\u201360.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"2346_CR68","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jmri.24611","volume":"41","author":"FA Chowdhury","year":"2015","unstructured":"Chowdhury FA, O\u2019Gorman RL, Nashef L, Elwes RD, Edden RA, Murdoch JB, et al. Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS. J Magn Reson Imaging. 2015;41:694\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"2346_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/nbm.1620","volume":"24","author":"I Hancu","year":"2011","unstructured":"Hancu I, Port J. The case of the missing glutamine. NMR Biomed. 2011;24:529\u201335.","journal-title":"NMR Biomed"},{"key":"2346_CR70","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.nicl.2019.101739","volume":"22","author":"LM Fleming","year":"2019","unstructured":"Fleming LM, Javitt DC, Carter CS, Kantrowitz JT, Girgis RR, Kegeles LS, et al. A multicenter study of ketamine effects on functional connectivity: large scale network relationships, hubs and symptom mechanisms. NeuroImage Clin. 2019;22:101739.","journal-title":"NeuroImage Clin"},{"key":"2346_CR71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","volume":"121","author":"RK Paul","year":"2014","unstructured":"Paul RK, Singh NS, Khadeer M, Moaddel R, Sanghvi M, Green CE, et al. (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. Anesthesiology 2014;121:149\u201359.","journal-title":"Anesthesiology"},{"key":"2346_CR72","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry J Assoc Eur Psychiatr. 2014;29:419\u201323.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"2346_CR73","doi-asserted-by":"publisher","first-page":"e03581","DOI":"10.7554\/eLife.03581","volume":"3","author":"OH Miller","year":"2014","unstructured":"Miller OH, Yang L, Wang CC, Hargroder EA, Zhang Y, Delpire E, et al. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine. eLife 2014;3:e03581.","journal-title":"eLife"},{"key":"2346_CR74","doi-asserted-by":"publisher","first-page":"12967","DOI":"10.1523\/JNEUROSCI.4297-06.2006","volume":"26","author":"JJ Radley","year":"2006","unstructured":"Radley JJ, Arias CM, Sawchenko PE. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J Neurosci. 2006;26:12967\u201376.","journal-title":"J Neurosci"},{"key":"2346_CR75","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/neu.20025","volume":"60","author":"SC Cook","year":"2004","unstructured":"Cook SC, Wellman CL. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol. 2004;60:236\u201348.","journal-title":"J Neurobiol"},{"key":"2346_CR76","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA. 2016;113:4853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2346_CR77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41586-020-2731-9","volume":"586","author":"S Vesuna","year":"2020","unstructured":"Vesuna S, Kauvar IV, Richman E, Gore F, Oskotsky T, Sava-Segal C, et al. Deep posteromedial cortical rhythm in dissociation. Nature 2020;586:87\u201394.","journal-title":"Nature"},{"key":"2346_CR78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharm Rev. 2018;70:621\u201360.","journal-title":"Pharm Rev"},{"key":"2346_CR79","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2125.2012.04198.x","volume":"74","author":"X Zhao","year":"2012","unstructured":"Zhao X, Venkata SLV, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, et al. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Br J Clin Pharm. 2012;74:304\u201314.","journal-title":"Br J Clin Pharm"},{"key":"2346_CR80","doi-asserted-by":"publisher","first-page":"e2013211","DOI":"10.1001\/jamanetworkopen.2020.13211","volume":"3","author":"MS Milak","year":"2020","unstructured":"Milak MS, Rashid R, Dong Z, Kegeles LS, Grunebaum MF, Ogden RT, et al. Assessment of relationship of ketamine dose with magnetic resonance spectroscopy of Glx and GABA responses in adults with major depression: a randomized clinical trial. JAMA Netw Open. 2020;3:e2013211\u2013e2013211.","journal-title":"JAMA Netw Open"},{"key":"2346_CR81","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fpsyt.2020.549903","volume":"11","author":"LR Silberbauer","year":"2020","unstructured":"Silberbauer LR, Spurny B, Handschuh P, Kl\u00f6bl M, Bednarik P, Reiter B, et al. Effect of ketamine on limbic GABA and glutamate: a human in vivo multivoxel magnetic resonance spectroscopy study. Front Psychiatry. 2020;11:920.","journal-title":"Front Psychiatry"},{"key":"2346_CR82","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/mp.2017.58","volume":"23","author":"I Esterlis","year":"2018","unstructured":"Esterlis I, DellaGioia N, Pietrzak RH, Matuskey D, Nabulsi N, Abdallah CG, et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression. Mol Psychiatry. 2018;23:824\u201332.","journal-title":"Mol Psychiatry"}],"updated-by":[{"DOI":"10.1038\/s41398-023-02377-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000}}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02346-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:02:59Z","timestamp":1677657779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02346-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41398-023-02377-7","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41398-023-02377-7","URL":"https:\/\/doi.org\/10.1038\/s41398-023-02377-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MW is a member of the following advisory boards and gave presentations to the following companies: Bayer AG, Germany; Boehringer Ingelheim, Germany; and Biologische Heilmittel Heel GmbH, Germany. MW has further conducted studies with institutional research support from HEEL and Janssen Pharmaceutical Research for a clinical trial (IIT) on ketamine in patients with MDD, unrelated to this investigation. MW did not receive any financial compensation from the companies mentioned above. All other authors report no biomedical financial interests or other potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}